Keywords: merck/novartis, dpp-4, inhibitors, lilly, ruboxistaurin, stars, ada

Merck/Novartis' DPP-4 inhibitors and Lilly's ruboxistaurin are stars of ADA 2006

Article | 19 June 2006

Print This

Betrween June 9 and 13, Washington DC played host to the 66th annual scientific sessions of the American Diabetes Association. Highlights of ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in